<code id='1F6013EAD5'></code><style id='1F6013EAD5'></style>
    • <acronym id='1F6013EAD5'></acronym>
      <center id='1F6013EAD5'><center id='1F6013EAD5'><tfoot id='1F6013EAD5'></tfoot></center><abbr id='1F6013EAD5'><dir id='1F6013EAD5'><tfoot id='1F6013EAD5'></tfoot><noframes id='1F6013EAD5'>

    • <optgroup id='1F6013EAD5'><strike id='1F6013EAD5'><sup id='1F6013EAD5'></sup></strike><code id='1F6013EAD5'></code></optgroup>
        1. <b id='1F6013EAD5'><label id='1F6013EAD5'><select id='1F6013EAD5'><dt id='1F6013EAD5'><span id='1F6013EAD5'></span></dt></select></label></b><u id='1F6013EAD5'></u>
          <i id='1F6013EAD5'><strike id='1F6013EAD5'><tt id='1F6013EAD5'><pre id='1F6013EAD5'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:3759
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Why don't Americans have at
          Why don't Americans have at

          NIAIDFluseasonisunderway.RSVisputtingrecordnumbersofchildreninhospitals.Andhealthprofessionalsaregea

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          First Opinion Podcast: Long Covid needs a new approach

          Sincetheearlydaysofthepandemic,longCovidhashauntedus:Evenamildacuteinfectionmightleaveyouwithlife-al